Affected populations: Acromegaly is estimated to affect approximately 50 to 70 people out of every million. However, the true ...

The case report by cardiologist Mahmoud Gomaa and colleagues from Kafrelsheikh University Hospital in Kafr el-Sheikh, Egypt, highlighted the potential complications of acromegaly. The patient ...

Biochemical control of acromegaly in noncured patients is usually defined as serum growth hormone (GH) levels <2.0 µg/l, plus normal-for-age serum levels of insulin-like growth factor I (IGF-I).

The FDA declined to approve investigational octreotide (CAM2029) extended-release injection for acromegaly, said developer Camurus, citing facility-related deficiencies identified during an ...